These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Sarcomere gene mutations--a cause of hypertrophic cardiomyopathy]. Kuusisto J; Jääskeläinen P; Laakso M Duodecim; 1999; 115(9):997-8. PubMed ID: 11877825 [No Abstract] [Full Text] [Related]
3. Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy. Dimitrow PP; Dubiel JS Heart; 2005 Jan; 91(1):93-4. PubMed ID: 15604346 [No Abstract] [Full Text] [Related]
4. Sudden cardiac death due to risperidone therapy in a patient with possible hypertrophic cardiomyopathy. Marti V Ann Pharmacother; 2005 May; 39(5):973. PubMed ID: 15827070 [No Abstract] [Full Text] [Related]
5. Myocardial bridging and sudden death in hypertrophic cardiomyopathy: Salome drops another veil. Olivotto I; Cecchi F; Yacoub MH Eur Heart J; 2009 Jul; 30(13):1549-50. PubMed ID: 19491131 [No Abstract] [Full Text] [Related]
6. Left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy. Elliott P; Gimeno J; Tomé M; McKenna W Eur Heart J; 2006 Dec; 27(24):3073; author reply 3073-4. PubMed ID: 17121751 [No Abstract] [Full Text] [Related]
10. Genetic screening and risk assessment in hypertrophic cardiomyopathy. MacRae CA; Ellinor PT J Am Coll Cardiol; 2004 Dec; 44(12):2326-8. PubMed ID: 15607393 [No Abstract] [Full Text] [Related]
11. Sudden cardiac death due to hypertrophic cardiomyopathy can be reduced by pre-participation cardiovascular screening in young athletes. Panhuyzen-Goedkoop NM; Verheugt FW Eur Heart J; 2006 Sep; 27(18):2152-3. PubMed ID: 16877480 [No Abstract] [Full Text] [Related]
12. Fatal potential of supraventricular tachycardia in hypertrophic cardiomyopathy. Munclinger MJ; Thornton AS; Schutte DP; Sliwa K Int J Cardiol; 2004 Feb; 93(2-3):335-7. PubMed ID: 14975578 [No Abstract] [Full Text] [Related]
13. Ten common questions about hypertrophic cardiomyopathy...and misconceptions. Maron BJ Cardiol Rev; 2005; 13(2):59-60. PubMed ID: 15705254 [No Abstract] [Full Text] [Related]
14. Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome. Mohiddin SA; Fananapazir L J Am Coll Cardiol; 2004 Mar; 43(6):1133; author reply 1133. PubMed ID: 15028383 [No Abstract] [Full Text] [Related]
15. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator]. Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866 [No Abstract] [Full Text] [Related]
17. When the heart in trouble is a young one. Dulak SB RN; 2006 May; 69(5):24ac1-5; quiz 24ac6. PubMed ID: 16722262 [No Abstract] [Full Text] [Related]
18. Sudden cardiac death in young athletes: trying to find the needle in the haystack. Ng B; Maginot KR WMJ; 2007 Sep; 106(6):335-42. PubMed ID: 17970016 [TBL] [Abstract][Full Text] [Related]
19. [Risk of sudden death according to the latest European guidelines on hypertrophic cardiomyopathy]. Iacovoni A; Quarta G; Senni M G Ital Cardiol (Rome); 2015 Mar; 16(3):143-6. PubMed ID: 25837457 [No Abstract] [Full Text] [Related]
20. Myocardial bridging in children with hypertrophic cardiomyopathy. Mohiddin SA; Begley D; Fananapazir L N Engl J Med; 1999 Jul; 341(4):288-90. PubMed ID: 10419391 [No Abstract] [Full Text] [Related] [Next] [New Search]